CervoMed Inc.CRVONASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank56
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P56
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
PeriodValue
Q4 2025-3.57%
Q3 2025-21.58%
Q2 2025-24.77%
Q1 202526.76%
Q4 2024-34.18%
Q3 2024-80.17%
Q2 2024-15.42%
Q1 2024-4.62%
Q4 20237.28%
Q3 2023-117.31%
Q2 202313.69%
Q1 202366.43%
Q4 2022-369.97%
Q3 202278.71%
Q2 20226.78%
Q1 2022-31.42%
Q4 202172.70%
Q3 2021-231.16%
Q2 202118.17%
Q1 2021-14.61%
Q4 202022.51%
Q3 2020-44.16%
Q2 2020-23.79%
Q1 20200.15%
Q4 20193.03%
Q3 2019-216.45%
Q2 2019189.80%
Q1 201990.98%
Q4 2018-364.14%
Q3 2018-126.48%
Q2 2018-191.87%
Q1 2018-83.45%
Q4 2017504.99%
Q3 2017212.24%
Q2 2017-16.13%
Q1 2017-107.51%
Q4 2016689.69%
Q3 2016-52.63%
Q2 201638.94%
Q1 2016-100.04%